SANUWAVE Health, Inc.  

(Public, OTCMKTS:SNWV)   Watch this stock  
Find more results for SNWV)
-0.0051 (-7.85%)
Jul 29 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.06 - 0.06
52 week 0.03 - 0.17
Open 0.06
Vol / Avg. 264,450.00/175,850.00
Mkt cap 6.24M
P/E     -
Div/yield     -
EPS -0.08
Shares 104.18M
Beta 0.40
Inst. own 11%
Aug 9, 2016
Q2 2016 SANUWAVE Health Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 16, 2016
Q1 2016 SANUWAVE Health Inc Earnings Release
May 16, 2016
Q1 2016 SANUWAVE Health Inc Earnings Call

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -640.35% -498.22%
Operating margin -256.38% -459.64%
EBITD margin - -437.85%
Return on average assets -612.37% -171.04%
Return on average equity - -
Employees 8 -
CDP Score - -


11475 Great Oaks Way Ste 150
ALPHARETTA, GA 30022-2482
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links


SANUWAVE Health, Inc. is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, enabling to restore the body's normal healing processes and regeneration. It is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 46
Lisa E. Sundstrom Chief Financial Officer
Age: 45
John F. Nemelka Director
Age: 49
A. Michael Stolarski Director
Alan L. Rubino Independent Director
Age: 60